Di Grazia, G.; Dri, A.; Grieco, A.; Martinelli, C.; Palleschi, M.; Martorana, F.; Barchiesi, G.; Arpino, G.; De Angelis, C.; De Laurentiis, M.;
et al. Unlocking the Potential of Immune Checkpoint Inhibitors in HR+/HER2− Breast Cancer: A Systematic Review. Cancers 2025, 17, 2940.
https://doi.org/10.3390/cancers17172940
AMA Style
Di Grazia G, Dri A, Grieco A, Martinelli C, Palleschi M, Martorana F, Barchiesi G, Arpino G, De Angelis C, De Laurentiis M,
et al. Unlocking the Potential of Immune Checkpoint Inhibitors in HR+/HER2− Breast Cancer: A Systematic Review. Cancers. 2025; 17(17):2940.
https://doi.org/10.3390/cancers17172940
Chicago/Turabian Style
Di Grazia, Giuseppe, Arianna Dri, Angela Grieco, Claudia Martinelli, Michela Palleschi, Federica Martorana, Giacomo Barchiesi, Grazia Arpino, Carmine De Angelis, Michelino De Laurentiis,
and et al. 2025. "Unlocking the Potential of Immune Checkpoint Inhibitors in HR+/HER2− Breast Cancer: A Systematic Review" Cancers 17, no. 17: 2940.
https://doi.org/10.3390/cancers17172940
APA Style
Di Grazia, G., Dri, A., Grieco, A., Martinelli, C., Palleschi, M., Martorana, F., Barchiesi, G., Arpino, G., De Angelis, C., De Laurentiis, M., Del Mastro, L., Puglisi, F., Vigneri, P., & Giuliano, M.
(2025). Unlocking the Potential of Immune Checkpoint Inhibitors in HR+/HER2− Breast Cancer: A Systematic Review. Cancers, 17(17), 2940.
https://doi.org/10.3390/cancers17172940
